When launching a beauty brand, one of the most common priorities is reducing manufacturing costs. At first glance, choosing a cheap OEM partner seems like a smart and strategic decision. Lower unit costs. Faster production. Attractive margins. But in reality, cheap OEM often leads to the most expensive outcomes—especially when entering the U.S. market. The Illusion of Saving Money Many brands focus heavily on cost per unit when selecting an OEM partner. However, manufacturing

K-beauty is built on speed. Fast development cycles, trend-driven innovation, and rapid product launches are what make the industry globally competitive. But when entering the U.S. market, that same speed—without a regulatory strategy—can quickly become a liability. What feels like momentum at the beginning often turns into unexpected costs later. The Problem: Compliance Is Often Treated as an Afterthought Many brands focus heavily on product development, packaging design, an

PDRN  is rapidly gaining attention as one of the most innovative ingredients in K-Beauty. From serums to post-procedure skincare, PDRN in skincare  is often marketed for its ability to support “skin regeneration,” improve recovery, and enhance overall skin quality. In Korea, these claims are widely used and well accepted. But when it comes to the U.S. market, PDRN claims require a completely different approach. The reason is simple: In the U.S., it’s not just about what PDRN

Entering the U.S. beauty market has never been more attractive—or more complex. For many K-Beauty brands, the first step is clear: find a manufacturer. But here’s the reality most brands discover too late: Finding a manufacturer is easy. Launching successfully in the U.S. is not. OEM and ODM partners can help you make a product. But building a brand that actually survives—and scales—in the U.S. requires much more. A real launch partner doesn’t stop at production. They bridge

As the demand for beauty devices continues to grow globally, many K-beauty manufacturers and U.S. buyers are exploring opportunities in this fast-evolving category. However, one critical question often arises early in the process: What makes a device a “beauty device,” and when does it become a medical device in the United States? The answer is not always straightforward. A common misconception is that classification depends primarily on marketing claims. While claims are imp

Entering the Korean beauty manufacturing ecosystem can be a significant competitive advantage for U.S. brands — but only when the right foundations are in place before the first conversation. Many early-stage brands approach OEM/ODM partners too quickly, without clear direction or regulatory awareness. This often leads to delays, misaligned expectations, or avoidable reformulation costs. To help you prepare effectively, here are the key areas every U.S. buyer should clarify b

The MedSpa industry in the United States is undergoing a quiet but significant transformation. Traditionally centered around in-clinic procedures — from laser treatments to injectables — MedSpas are now expanding beyond services and into retail. More specifically, they are building their own private-label skincare brands. This shift is not just a trend. It is a strategic evolution. The Limitations of Treatment-Only Models While treatments can be highly profitable, they come w

The U.S. cosmetics industry is undergoing a structural shift — and the data clearly reflects it. According to the U.S. Food and Drug Administration, adverse event reports increased from 5,497 cases in 2023  to 27,682 cases in 2024 , following the implementation of the MoCRA.This represents an approximately fivefold increase in reported cases within a single year . As of the first quarter of 2026, 4,498 cases have already been recorded , indicating that elevated reporting le

K-Beauty has earned a global reputation for its innovative formulations, cutting-edge ingredients, and rapid product development. Many Korean brands have successfully expanded across Asia and Europe, yet when it comes to the U.S. market, even well-loved products often struggle — or outright fail. The reason isn’t lack of quality; it’s about how products are positioned, distributed, and regulated. If you’re a K-Beauty brand considering U.S. expansion, it’s crucial to understan

A fast-growing K-Beauty brand — call it Brand A — recently appeared in not one but two FDA public databases. First in CAERS, the FDA's cosmetics adverse event reporting system. Then in MAUDE, the medical device adverse event database. No recall. No import alert. But showing up across two separate FDA systems at the same time? That kind of thing gets noticed. Why an FDA Database Listing Is Never Just a Footnote CAERS and MAUDE are fully public. No login required. Any consumer,

Cosmoprof North America Miami 2026  is the continent's largest B2B beauty and wellness exhibition, bringing together industry leaders from around the globe. GlowBridge hosted its own booth at this year’s event, engaging directly with American and international buyers. The enthusiasm for K-Beauty was palpable, with a constant stream of inquiries regarding various brands and product categories. While conversations spanned a wide range of topics, buyers consistently circled back

As an Amazon seller, you might face the sudden deactivation of a listing or receive a warning email without any notice. Many sellers, caught off guard, rush to appeal or submit unprepared documents. This, however, can escalate the situation and even lead to a full account suspension. Since Amazon requires a specific and verifiable plan for improvement, a systematic response is crucial. In this guide, we've broken down the steps and survival strategies for when you receive a w

An Amazon seller, let's call her A, once updated a single line on her cosmetic product label and suddenly her listing was deactivated. It turned out that one of the ingredients in her product was added to Amazon’s new prohibited list, causing her a significant financial loss. Amazon has been rapidly tightening its regulations over the last few years. The year 2025, in particular, has seen a noticeable increase in the strictness of rules for cosmetics, dietary supplements, and

Gen Z is a generation that values the meaning conveyed  over the visual appearance . For them, the functionality of a product is as important as its packaging, labeling, and communication style aligning with their personal values. Eco-friendly packaging, refillable containers, understated text, and an unboxing experience worthy of sharing on social media—all these factors are becoming selection criteria for beauty products just as crucial as the product itself. Why Gen Z Emph

"Can I ship this to the U.S. without any issues?" "My Amazon listing suddenly disappeared. Why is that?""I heard U.S. Customs is cracking down again because of MoCRA..." The Modernization of Cosmetics Regulation Act (MoCRA) , which officially took effect in late 2023, has brought the biggest shake-up to the U.S. cosmetics market in decades. Korean brands, manufacturers, and even beauty sellers within the U.S. are directly experiencing the impacts of this new regulation. While

In the United States, sunscreens are regulated as OTC (Over-the-Counter) drugs , not cosmetics. This means they are subject to strict regulatory frameworks governing everything from ingredients and SPF testing to labeling and safety standards. Recent FDA announcements do not necessarily mean an immediate overhaul of all existing rules. Instead, they signal a strategic update to OTC Monograph M020 , clarifying the standards and direction for future sunscreen regulations. How i

The Next Frontier for K-Beauty: The Rise of "K-Beauty Devices" The global phenomenon of K-Beauty is no longer confined to skincare and cosmetics. By combining innovative ingredients and fast-paced trends with advanced technology, a new wave of "K-Beauty Devices" (or K-Devices) is rapidly gaining traction in the U.S. This category spans from at-home skin management devices and LED masks to MedSpa-inspired home-care tools that treat the face, scalp, and body simultaneously. U.S